Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug
about
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverStructure and functionality in flavivirus NS-proteins: perspectives for drug designEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbola haemorrhagic feverMultiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakRift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteinsPre-symptomatic diagnosis and treatment of filovirus diseasesUnderstanding the dengue viruses and progress towards their controlRandomized, Placebo-Controlled Trial of Nonpegylated and Pegylated Forms of Recombinant Human Alpha Interferon 2a for Suppression of Dengue Virus Viremia in Rhesus MonkeysIn Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus InfectionsIdentification of Novel Small-Molecule Inhibitors of West Nile Virus InfectionRibavirin Reveals a Lethal Threshold of Allowable Mutation Frequency for Hantaan VirusMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsA global perspective on hantavirus ecology, epidemiology, and diseaseEbola Viral Disease in West Africa: A Threat to Global Health, Economy and Political StabilityProgress towards the treatment of Ebola haemorrhagic fever.Updates in diagnosis and management of Ebola hemorrhagic fever.Viral haemorrhagic fever in Sweden: experiences from management of a case.In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus.Toxicologic effects of ribavirin in cats.Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsComparison of the chronic effects of ribavirin and caffeic acid phenethyl ester (CAPE) on pancreatic damage and hepatotoxicity.Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.Perspectives for the treatment of infections with Flaviviridae.Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.West Nile encephalitis: an emerging disease in the United States.Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsEbola virus disease: an update for anesthesiologists and intensivists.Treatment of ebola virus disease.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systemsWest Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.Challenges for the development of ribonucleoside analogues as inducers of error catastrophe.Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic ImplicationsPathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cellsEvaluation of Lassa antiviral compound ST-193 in a guinea pig model.Exotic emerging viral diseases: progress and challenges.
P2860
Q21092271-E95EC224-E899-4D23-A34D-082222DD00D4Q23011530-E6E43C9D-B079-425F-A6C6-F0AD82DC4D26Q24597625-3B83DEF4-98F1-4149-98EC-7F577912EF38Q24629338-8C690862-79CD-4F78-87A5-2574373FDF5CQ24701722-D5F61EC0-1D99-45C2-AFEC-18524CD553D4Q26745530-7917000E-2338-4371-97DF-A7E513FDCBA6Q26823831-DCBB013C-72D0-4119-993A-4422B48C69C1Q27011587-707ED75C-5A45-4944-84B0-319F475D4A2EQ27472702-5B8E7920-EEBF-412A-9476-0D2F9E27E01CQ27481401-7897377C-A1FE-45DF-B5FB-ABB400F676B3Q27484983-B6DD9FE8-DBFC-447C-9F21-1348CE049DDFQ27484998-D8DFE95E-2393-4488-8D93-2217665EF639Q28072953-4768CD14-9910-4D1D-BA04-ADACA25B4377Q28279096-F413EC64-4FEB-4021-96E9-10E000DAD91AQ30148821-273F6D21-7144-4CDB-9562-0DE5923A5BA8Q30230272-81206006-D4A1-4644-98ED-F5026C9CB43BQ30238537-BAB35A81-A139-4BBF-9AFA-85C2278A25A6Q33379867-CB7CF351-AF19-4C31-899D-39A1111CBCECQ33437185-30CDB158-B042-422E-B540-2F4A84B9DC5DQ33493051-2F6386AA-D3EF-41BC-BC63-AB34220AEABEQ33705717-9708B3DF-E539-474E-A874-750CA632DB2DQ33756297-47EA5910-BA54-4D71-AEF4-4659A0EC7DE9Q33780460-18BA5348-14D9-4526-96CC-36AF96EEA21EQ33812419-71624E85-5BFC-4FA8-B186-C42876400F92Q33840716-5CE9F118-85AB-44D3-9D35-09E254FD3419Q34040052-C5BED395-0178-4B8E-8F94-3CA021E1416BQ34246661-47384130-91DC-4E64-B4E6-223C74F88072Q34274569-8990A14D-2017-43B0-A1DA-D48A56A67627Q34398570-886E6803-E5EB-4288-8601-A137F00D0E67Q34432483-89E6F555-F99E-4CF1-BBD2-30638D6B7715Q34446478-6EE1DCE0-48F3-482F-9924-28E9CDA933F0Q34460182-EFF6096E-6B1D-4F39-ADF4-EE759FEAF0C3Q34971349-761DA72D-C4AE-483E-A258-11A1F8DDE066Q34996107-9589796D-C140-48F2-B658-E2A79D87396CQ35549286-9E4F3EF1-B388-412E-AAF5-88F063A380F1Q35742174-A904196C-F3B4-4F33-BBF7-E932E1878FF5Q35784542-835B8AE5-1700-46E1-A1DB-39EDC289B4D7Q35843339-45F408D5-3968-457B-91DB-48A62564FC1AQ35870592-7DF26B4A-31F2-4345-A322-A9617597F884Q35971398-3ACBFBD7-9479-4AF3-99AA-6CFE5831288C
P2860
Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug
description
1989 nî lūn-bûn
@nan
1989 թուականին հրատարակուած գիտական յօդուած
@hyw
1989 թվականին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@ast
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@en
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@nl
type
label
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@ast
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@en
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@nl
prefLabel
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@ast
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@en
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@nl
P3181
P1476
Prospects for treatment of vir ...... broad-spectrum antiviral drug
@en
P2093
J W Huggins
P304
P3181
P356
10.1093/CLINIDS/11.SUPPLEMENT_4.S750
P407
P478
11 Suppl 4
P577
1989-01-01T00:00:00Z